1-20 of 111
Authors: G Van Assche
Sort by
Journal Article
OP37 Fibrogenesis in chronic DSS colitis is driven by an innate lymphoid cell-independent innate immune response
B Creyns and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S038–S039, https://doi.org/10.1093/ecco-jcc/jjz203.036
Published: 15 January 2020
Journal Article
DOP83 Intestinal fibrosis in Crohn’s disease patients is marked by up-regulation of innate immune cells and mucosal B cells
B Creyns and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S122–S123, https://doi.org/10.1093/ecco-jcc/jjz203.122
Published: 15 January 2020
Journal Article
P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients
L Fierens and others
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S250–S252, https://doi.org/10.1093/ecco-jcc/jjz203.348
Published: 15 January 2020
Journal Article
P385 TREM1, the first anti-TNF specific biomarker guiding therapeutic decision
Get access
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S300, https://doi.org/10.1093/ecco-jcc/jjy222.509
Published: 25 January 2019
Journal Article
DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's disease
Get access
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S072–S073, https://doi.org/10.1093/ecco-jcc/jjy222.104
Published: 25 January 2019
Journal Article
P155 Adherence to quality indicators among patients with inflammatory bowel disease: an international comparative analysis
Get access
A Weizman and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S166–S167, https://doi.org/10.1093/ecco-jcc/jjy222.279
Published: 25 January 2019
Journal Article
P311 Pharmacokinetics and exposure–response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
Get access
O J Adedokun and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S255–S256, https://doi.org/10.1093/ecco-jcc/jjy222.435
Published: 25 January 2019
Journal Article
P821 Distinct and common gene expression profiles between inflamed ileum and colon of newly diagnosed CD patients
Get access
S Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S533, https://doi.org/10.1093/ecco-jcc/jjy222.945
Published: 25 January 2019
Journal Article
P032 Hepatocyte growth factor and MET in ulcerative colitis, novel drug targets impairing neutrophil recruitment?
Get access
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S102, https://doi.org/10.1093/ecco-jcc/jjy222.156
Published: 25 January 2019
Journal Article
P542 Efficacy and safety of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single-centre experience
Get access
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S385, https://doi.org/10.1093/ecco-jcc/jjy222.666
Published: 25 January 2019
Journal Article
P820 Molecular changes in non-inflamed terminal ileum in patients with ulcerative colitis
Get access
H-S Lee and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S533–S534, https://doi.org/10.1093/ecco-jcc/jjy222.944
Published: 25 January 2019
Journal Article
P312 Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI
Get access
B E Sands and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S256–S257, https://doi.org/10.1093/ecco-jcc/jjy222.436
Published: 25 January 2019
Journal Article
P827 Up-regulation of IL17-related pathways in affected colon from ulcerative colitis compared with Crohn’s disease
Get access
S Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S537–S538, https://doi.org/10.1093/ecco-jcc/jjy222.951
Published: 25 January 2019
Journal Article
DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients
Get access
B Creyns and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S040, https://doi.org/10.1093/ecco-jcc/jjy222.061
Published: 25 January 2019
Journal Article
DOP38 A vedolizumab specific four-gene colonic signature accurately predicting future endoscopic remission in patients with inflammatory bowel disease
Get access
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S048, https://doi.org/10.1093/ecco-jcc/jjy222.072
Published: 25 January 2019
Journal Article
DOP54 Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial
Get access
S Danese and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S061–S062, https://doi.org/10.1093/ecco-jcc/jjy222.088
Published: 25 January 2019
Journal Article
OP37 Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI
Get access
W J Sandborn and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S025–S026, https://doi.org/10.1093/ecco-jcc/jjy222.034
Published: 25 January 2019
Journal Article
P001 Multi-omic data integration assisted identification of molecular features contributing to disease heterogeneity in Crohn's disease
Get access
P Sudhakar and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S085–S086, https://doi.org/10.1093/ecco-jcc/jjy222.125
Published: 25 January 2019
Journal Article
DOP37 Vedolizumab-induced endoscopic remission in anti-TNF exposed and anti-TNF naïve IBD patients: a large single-centre experience
Get access
B Verstockt and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S047–S048, https://doi.org/10.1093/ecco-jcc/jjy222.071
Published: 25 January 2019
Journal Article
DOP47 Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase 3 UNIFI maintenance study
Get access
G Van Assche and others
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S054–S055, https://doi.org/10.1093/ecco-jcc/jjy222.081
Published: 25 January 2019
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals